The book offers a critical investigation into the use of psychotropic drugs to pacify and control inmates and other captives in the vast US prison, military, and welfare systems.
According to the publisher:
Anthony Ryan Hatch demonstrates that the pervasive use of psychotropic drugs has not only defined and enabled mass incarceration but has also become central to other forms of captivity, including foster homes, military and immigrant detention centers, and nursing homes.
For residents of state-managed institutions, the American Dream too often has been warped into a drug-addled nightmare. Combining novel insights supported by rigorous scholarship with fresh, accessible writing, Hatch presents a powerful indictment of imposing psychotropics upon the caged powerless, building an unimpugnable case that unveils a deeply troubling pattern and also affords us the chance to end it.
The book is a critical investigation into the use of psychotropic drugs to pacify and control inmates and other captives in the vast U.S. prison, military, and welfare systems.
According to the publisher:
“For at least four decades, U.S. prisons and jails have aggressively turned to psychotropic drugs—antidepressants, antipsychotics, sedatives, and tranquilizers—to silence inmates, whether or not they have been diagnosed with mental illnesses. In Silent Cells, Anthony Ryan Hatch demonstrates that the pervasive use of psychotropic drugs has not only defined and enabled mass incarceration but has also become central to other forms of captivity, including foster homes, military and immigrant detention centers, and nursing homes.
The topic of the 26th Annual Dwight L. Greene Symposium on Sept. 29 was titled “Black Phoenix Rising,” a project consisting of multimedia, digital scholarship, and cultural arts exploring black peoples’ ways of resisting material and symbolic death in American life and culture.
Associate Professor Anthony Hatch. (Photo by Robert Adam Mayer)
Wesleyan faculty frequently publish articles based on their scholarship in The Conversation US, a nonprofit news organization with the tagline, “Academic rigor, journalistic flair.” In a new article, Associate Professor of Sociology Anthony Hatch writes about troubling ethical questions raised by the emergence of a new type of digital drug, which contains a sensor that communicates back information about the patient to doctors and pharmaceutical companies. Hatch is also associate professor of science in society, associate professor of African American studies.
Digital mental health drug raises troubling questions
Moments after Neo eats the red pill in “The Matrix,” he touches a liquefied mirror that takes over his skin, penetrating the innards of his body with computer code. When I first learned about the controversial new digital drug Abilify MyCite, I thought of this famous scene and wondered what kinds of people were being remade through this new biotechnology.
Otsuka Pharmaceuticals and Proteus Digital Health won Food and Drug Administration approval to sell Abilify MyCite in late 2017. This drug contains a digital sensor embedded within the powerful antipsychotic drug Abilify, the brand name for aripiprazole, which is used to treat schizophrenia, bipolar disorder and major depressive disorder. The goal of the digital sensor is for doctors to monitor their patients’ intake of Abilify MyCite remotely and ensure that the patient is adhering to the correct drug dose and timing.
Pills with embedded sensors mark a new era in digital health and, I believe, herald the arrival of a new kind of digital cyborg identity, which sociologist Deborah Lupton defines as “the body that is enhanced, augmented or in other ways configured by its use of digital media technologies.” Drugs are cybernetic technologies in that we absorb pharmaceuticals through metabolic processes that biochemically recode our brains and bodies.
The figure of the cyborg helps us recognize the potential of digital health technologies for enhancing human health, while at the same time critique how the practices of digital health can work to coerce, marginalize or transform individual people and entire social groups. In my view, having pills that connect us to our doctor and pharmaceutical companies via an app is dehumanizing and reduces patients’ psychic lives to a digital readout.
From left, Anthony Ryan Hatch, Basak Kus and Courtney Weiss Smith.
In its most recent meeting, the Board of Trustees conferred tenure to Anthony Ryan Hatch, associate professor of science in society; Basak Kus, associate professor of sociology; and Courtney Weiss Smith, associate professor of English. Their appointments begin on July 1.
In addition, seven faculty members are being promoted: Abderrahman Aissa, adjunct assistant professor of Arabic; Balraj Balasubrahmaniyan, adjunct associate professor of music; Daniel DiCenzo, adjunct professor of physical education; Michael Fried, adjunct professor of physical education; Ruth Nisse, professor of English; Ulrich Plass, professor of German studies; and Kim Williams, adjunct associate professor of physical education.
Brief descriptions of their research and teaching appear below.
Abderrahman Aissa teaches elementary, intermediate and advanced Arabic. He is the editor of, and a chief contributor to, the bilingual Arabic-English cultural and political magazine, Zarah.